BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Prognosis
19 results:

  • 1. Comparison of clinical characteristics and prognosis in endometrial carcinoma with different pathological types: a retrospective population-based study.
    Zhang G; Nie F; Zhao W; Han P; Wen J; Cheng X; Wu W; Liu Q; Sun Y; Wang Y; Liu Y; Ren F
    World J Surg Oncol; 2023 Nov; 21(1):357. PubMed ID: 37986077
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. An endoplasmic reticulum stress-related signature could robustly predict prognosis and closely associate with response to immunotherapy in pancreatic ductal adenocarcinoma.
    Liu S; Hu Q; Xie Z; Chen S; Li Y; Quan N; Huang K; Li R; Fang L
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15589-15608. PubMed ID: 37653101
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. cd74 Promotes a Pro-Inflammatory Tumor Microenvironment by Inducing S100A8 and S100A9 Secretion in pancreatic cancer.
    Hong WC; Lee DE; Kang HW; Kim MJ; Kim M; Kim JH; Fang S; Kim HJ; Park JS
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629174
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. BUB1 Is Identified as a Potential Therapeutic Target for pancreatic cancer Treatment.
    Li M; Duan X; Xiao Y; Yuan M; Zhao Z; Cui X; Wu D; Shi J
    Front Public Health; 2022; 10():900853. PubMed ID: 35769782
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Single-cell RNA-seq reveals the genesis and heterogeneity of tumor microenvironment in pancreatic undifferentiated carcinoma with osteoclast-like giant-cells.
    Wang X; Miao J; Wang S; Shen R; Zhang S; Tian Y; Li M; Zhu D; Yao A; Bao W; Zhang Q; Tang X; Wang X; Li J
    Mol Cancer; 2022 Jun; 21(1):133. PubMed ID: 35733218
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Swann R; Johnson SA; Barclay ME; Abd Elkader H; Alvi R; Barisic A; Bucher O; Clark GRC; Creighton N; Danckert B; Denny CA; Donnelly DW; Dowden JJ; Finn N; Fox CR; Fung S; Gavin AT; Gomez Navas E; Habbous S; Han J; Huws DW; Jackson CGCA; Jensen H; Kaposhi B; Kumar SE; Little AL; Lu S; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Te Marvelde L; Thomas RS; Thomas RJS; Thomson CS; Woods RR; Zhang B; Lyratzopoulos G;
    Lancet Oncol; 2022 May; 23(5):587-600. PubMed ID: 35397210
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The prognostic value of intratumoral and peritumoral tumor-infiltrating FoxP3+Treg cells in of pancreatic adenocarcinoma: a meta-analysis.
    Hu L; Zhu M; Shen Y; Zhong Z; Wu B
    World J Surg Oncol; 2021 Oct; 19(1):300. PubMed ID: 34654443
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. cd74 promotes perineural invasion of cancer cells and mediates neuroplasticity via the AKT/EGR-1/GDNF axis in pancreatic ductal adenocarcinoma.
    Zhang JF; Tao LY; Yang MW; Xu DP; Jiang SH; Fu XL; Liu DJ; Huo YM; Liu W; Yang JY; Hua R; Lu P; Sun YW
    Cancer Lett; 2021 Jun; 508():47-58. PubMed ID: 33766751
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Elevated Preoperative Serum CA125 Predicts Larger Tumor Diameter in Patients with Hepatocellular Carcinoma and Low AFP Levels.
    Zhou S; Wang Z; Li M; Wu L
    Biomed Res Int; 2019; 2019():6959637. PubMed ID: 31662990
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. FGFR1 expression defines clinically distinct subtypes in pancreatic cancer.
    Haq F; Sung YN; Park I; Kayani MA; Yousuf F; Hong SM; Ahn SM
    J Transl Med; 2018 Dec; 16(1):374. PubMed ID: 30593273
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Is Neoadjuvant Therapy Sufficient in Resected pancreatic cancer Patients? A National Study.
    de Geus SWL; Kasumova GG; Eskander MF; Ng SC; Kent TS; James Moser A; Vahrmeijer AL; Callery MP; Tseng JF
    J Gastrointest Surg; 2018 Feb; 22(2):214-225. PubMed ID: 29235000
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Decreased RGS6 expression is associated with poor prognosis in pancreatic cancer patients.
    Jiang N; Xue R; Bu F; Tong X; Qiang J; Liu R
    Int J Clin Exp Pathol; 2014; 7(7):4120-7. PubMed ID: 25120791
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effect of cd74 on the prognosis of patients with resectable pancreatic cancer.
    Zhang JF; Hua R; Liu DJ; Liu W; Huo YM; Sun YW
    Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):81-6. PubMed ID: 24463084
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients.
    He W; Tang B; Yang D; Li Y; Song W; Cheang T; Chen X; Li Y; Chen L; Zhan W; Li W; He Y
    World J Surg Oncol; 2013 Jul; 11():161. PubMed ID: 23866030
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Target proteomic profiling of frozen pancreatic CD24+ adenocarcinoma tissues by immuno-laser capture microdissection and nano-LC-MS/MS.
    Zhu J; Nie S; Wu J; Lubman DM
    J Proteome Res; 2013 Jun; 12(6):2791-804. PubMed ID: 23679566
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Survival analysis of patients with spontaneous rupture of hepatocellular carcinoma].
    Zhao GG; Xu W; Tian YH; Li DX
    Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):838-42. PubMed ID: 23206303
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma.
    Kaffenberger SD; Morgan TM; Stratton KL; Boachie AM; Barocas DA; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
    BJU Int; 2012 Dec; 110(11 Pt B):E641-6. PubMed ID: 22958439
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. cd74 is a novel prognostic factor for patients with pancreatic cancer receiving multimodal therapy.
    Nagata S; Jin YF; Yoshizato K; Tomoeda M; Song M; Iizuka N; Kitamura M; Takahashi H; Eguchi H; Ohigashi H; Ishikawa O; Tomita Y
    Ann Surg Oncol; 2009 Sep; 16(9):2531-8. PubMed ID: 19499276
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (cd74) as a possible molecule involved in perineural invasion in pancreatic cancer.
    Koide N; Yamada T; Shibata R; Mori T; Fukuma M; Yamazaki K; Aiura K; Shimazu M; Hirohashi S; Nimura Y; Sakamoto M
    Clin Cancer Res; 2006 Apr; 12(8):2419-26. PubMed ID: 16638847
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.